FDA Guidance Series on Patient-Focused Drug Development (PFDD) to Enhance Product Development and Regulatory Decision Making
As the industry continues to adopt a patient-centric approach, the use of real-world data is...
As the industry continues to adopt a patient-centric approach, the use of real-world data is...
Veristat’s Science Advisory Board met on 14 March 2023 to discuss Executing Patient-Focused Drug...
In the world of biotechnology, where groundbreaking discoveries have the potential to change lives,...
In today's world where digital transformation is reshaping industries, even the pharmaceutical...
Veristat, in partnership with TOPRA, recently hosted an insightful webinar titled "Future Trends on...
Veristat and TOPRA recently hosted an informative webinar on the topic of the impact of new EU...
Explore the growing role of Real-World Evidence (RWE) in the regulatory decision-making process...
Project Optimus is an initiative from the FDA Oncology Center of Excellence led by Drs. Mirat Shah...